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Abstract
We report an extremely rare case of synchronous development of two 
distinct primary tumors, nasopharyngeal carcinoma (NPC) and renal cell 
carcinoma (RCC). A 47-year-old man with a longstanding smoking history 
presented with bilateral neck masses. NPC was confirmed by biopsy and 
a pathology report. However, during the staging process, a left middle 
renal solid mass was detected by abdominal computed tomography, and 
the follow-up computed tomography-guided biopsy revealed clear cell 
type RCC. The patient was treated with concurrent chemoradiation ther-
apy and left nephrectomy for the NPC and RCC, respectively. In addition 
to the clinically common risk of cigarette smoking for both NPC and RCC, 
the biological similarity of NPC and RCC cell lines has also been docu-
mented in some in vitro studies. Awareness of the possible simultaneous 
occurrence of these two malignancies and inclusion of the nasopharynx 
and kidneys in the staging processes for RCC and NPC might help shed 
more light on their clinical correlation. [Tzu Chi Med J 2010;22(1):58–60]
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1. Introduction
Nasopharyngeal carcinoma (NPC) is a squamous cell 
carcinoma that occurs in the nasopharyngeal epithe-
lium with an unusually variable incidence rate from 
0.5–2/105 in western countries to 6.5/105 in Taiwan 
[1,2]. There are three unique etiologic factors of NPC: 
genetic susceptibility, chemical carcinogens such as 
tobacco, and Epstein-Barr virus infection.
Renal cell carcinoma (RCC), which originates within 
the renal cortex, is responsible for 80–85% of all pri-
mary renal neoplasms. RCC accounts for 1.3% of the 
total cancer mortality in Taiwan [2], and an increas-
ing incidence rate over the past 10 years has been 
reported [3]. Tobacco smoking has been described 
as a major risk factor for RCC [4,5].
Both NPC and RCC are known to have a tendency 
towards early metastasis. One third of patients with 
RCC have metastatic disease at diagnosis. The most fre-
quent site of distant metastasis for both RCC and NPC 
is the lung [6]. However, simultaneous NPC and RCC is 
extremely rare, with only two other cases reported in 
the English literature. We report here a third case with 
incidental RCC found during the NPC staging process.
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Fig. 1 — Magnetic resonance imaging of the neck and nasopharynx shows (A) a right subepithelial nasopharyngeal 
mass, 1.8 cm in diameter, and (B) bilateral lymphadenopathy with the largest lymph node 2.7 cm in diameter.
Fig. 2 — Excisional biopsy of the left level V neck mass 
shows undifferentiated nasopharyngeal carcinoma, WHO 
type III (hematoxylin & eosin, 400´).
2. Case report
A 47-year-old man was admitted to our hospital be-
cause of bilateral neck masses without any symptoms 
such as nasal obstruction, epistaxis, or serous otitis. 
He had a history of smoking one and a half packs of 
cigarettes daily, and had also chewed betel nuts for 
more than 20 years. His neck masses were immovable 
and elastic with smooth surfaces. Otolaryngoscopic 
examination showed no abnormal findings. Magnetic 
resonance imaging of the neck and nasopharynx re-
vealed a subepithelial nasopharyngeal mass, 1.8 cm in 
diameter, and bilateral lymphadenopathy (the largest 
lymph node was 2.7 cm in diameter; Fig. 1). Pathology 
examination of the excisional biopsy of the left side 
level V neck lymph node, measuring 2.5 × 2.0 × 2.0 cm, 
showed a metastatic carcinoma with NPC histology, 
WHO type III (Fig. 2). During the NPC staging process, 
abdominal computed tomography detected an inci-
dental solid mass 4.7 cm in diameter, in the middle 
segment of the left kidney. Computed tomography-
guided biopsy of the mass revealed clear cell type 
RCC (Fig. 3).
The patient received radiotherapy for NPC 2 weeks 
after the renal biopsy but left nephrectomy was de-
layed for 4 weeks because of septic arthritis of the 
right hip. The renal tumor was stage pT1bN0M0 with 
no invasion to the renal artery, renal vein, ureter or 
perirenal adipose tissue. Chemotherapy for NPC com-
menced 2 weeks after nephrectomy. Thirteen months 
after nephrectomy, the patient was in a stable condi-
tion and was followed-up at both the urology and 
otolaryngology clinics.
3. Discussion
Our patient had two distinct synchronous primary tu-
mors, NPC and RCC. To our knowledge, this rare combi-
nation has been reported previously in only two patients 
[7,8], one with concurrent NPC and RCC [8] and one in 
which RCC was diagnosed 5 years after NPC [7].
The patient received radiotherapy for NPC stage 
cT1N3bM0 2 weeks after the renal biopsy, but left ne-
phrectomy was delayed for 4 weeks because of sep-
tic arthritis of the right hip. Since our patient’s NPC 
stage was stage IVb, the treatment of choice for locally 
advanced NPC is concurrent chemo radiation therapy 
[9]. The benefit of chemotherapy was confirmed in a 
meta-analysis of 78 randomized controlled trials (9279 
patients) comparing radiotherapy with and without 
chemotherapy. Radiotherapy proceeded as usual in 
our patient, but chemotherapy was delayed because 
of septic arthritis and nephrectomy. The RCC stage 
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was pT1bN0M0, stage I and the gold standard treat-
ment is radical nephrectomy without any adjuvant 
therapy; this was performed after septic arthritis had 
been controlled. The 5-year overall survival rates of 
stage IVb NPC and stage I RCC are approximately 
58% and 95%, respectively [10,11].
Smoking is a common major risk factor for both 
NPC and RCC. It has been reported that the probability 
of developing RCC increases approximately twofold 
with cigarette smoking and nearly one third of RCC 
cases involve smoking [4,5]. Furthermore, long-term 
smoking has been confirmed to be associated with 
NPC in Taiwan [12].
Interestingly, the biological similarity of in vitro 
NPC and RCC cell lines was implied by one com-
parative study, in which tumorigenicity was inhibited 
in both cell lines when chromosome 3 was trans-
ferred into the cells [13]. Moreover, treatment of NPC 
and RCC cell lines with histone deacetylase inhibi-
tors shows a similar pattern of alteration of gene 
expression [14].
Simultaneous presentation of NPC and RCC is 
quite rare, and only one case has been reported in 
the literature. Although little is known about this type 
of presentation, the similar in vitro behavior indicates 
a link between the NPC and RCC cell lines. Awareness 
of this simultaneous presentation and inclusion of the 
nasopharynx and kidneys in the screening and staging 
processes of RCC and NPC might result in detection 
of more analogous cases and help elucidate their 
clinical relevance.
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Fig. 3 — (A) Abdominal computed tomography (CT) re-
veals a left renal solid mass, 4.7 cm in diameter. (B) CT-
guided biopsy of the mass shows clear cell type renal cell 
carcinoma (hematoxylin & eosin, 400´).
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